title: [Treatment refractory hypertension with atrophic kidney: attending to one and not neglecting the other].
abstract: The incidence of primary aldosteronism in patients with difficult to treat hypertension is higher than previously stated in texts. The clinical picture of hypokalemic hypertensive patients remains unreliable as a third of the patients are normokalemic. Considering the diagnosis is the most important step in diagnosing primary aldosteronism. The clinical suspicion has to be confirmed biochemically.
authors.affiliation: Medizinische Poliklinik, Departement InnereMedizin, Universitätsspital Zürich.
authors.forename: M
authors.initials: M
authors.lastname: Guertler
authors.forename: W
authors.initials: W
authors.lastname: Vetter
authors.forename: P M
authors.initials: PM
authors.lastname: Suter
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001284:Atrophy; D003937:Diagnosis, Differential; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D006801:Humans; D006929:Hyperaldosteronism / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology; D007668:Kidney / Q000473:pathology*; D008297:Male; D013148:Spironolactone / Q000008:administration & dosage
chemical_list: D000959:Antihypertensive Agents; D013148:Spironolactone